Rejoinder: estimands and their estimators for clinical trials impacted by the COVID-19 pandemic: a report from the NISS ingram Olkin forum series on unplanned clinical trial disruptions

MLA

Kelly Van Lancker, et al. Rejoinder: Estimands and Their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions. Dec. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cbe97462c5e30ef45f78db519d194421&authtype=sso&custid=ns315887.

APA

Kelly Van Lancker, Sergey Tarima, Jonathan Bartlett, Madeline Bauer, Bharani Bharani-Dharan, Frank Bretz, Nancy Flournoy, Hege Michiels, Camila Olarte Parra, James L Rosenberger, & Suzie Cro. (2022). Rejoinder: estimands and their estimators for clinical trials impacted by the COVID-19 pandemic: a report from the NISS ingram Olkin forum series on unplanned clinical trial disruptions.

Chicago

Kelly Van Lancker, Sergey Tarima, Jonathan Bartlett, Madeline Bauer, Bharani Bharani-Dharan, Frank Bretz, Nancy Flournoy, et al. 2022. “Rejoinder: Estimands and Their Estimators for Clinical Trials Impacted by the COVID-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cbe97462c5e30ef45f78db519d194421&authtype=sso&custid=ns315887.